What a nice experience for our CSO to represent Amyl in Boston at the world’s largest biotech gathering ! More than 20,000 professionals from accross the globe attended.
Damien Toulorge shared our technology and recent advances. This was a great recognition for our scientific team and a unique opportunity to highlight our commitment to neurodegenerative diseases.
About Merieux Equity Partners
Mérieux Equity Partners (MxEP) is an AMF-accredited management company dedicated to equity investments in healthcare. MxEP actively supports entrepreneurs and companies with differentiated products and services, giving them privileged access to its sector expertise and international network. MxEP currently manages c.€1.5bn ($1.6bn) AUM.
About Noshaq Partners
Noshaq is a Belgian investment fund and project developer with a portfolio of 477 companies. Noshaq is the reference financial partner for the creation and development of SMEs in the Liege region (Wallonia). Over the years, it has developed a range of financing vehicles in line with the needs and trends of the market and its strategy. Each service offered by Noshaq (capital – loan – leasing) is always determined according to the demands and needs of the owner-investor. Its objective is always to have a leverage effect on the company’s development.
About Sambrinvest
With over 35 years of experience working alongside companies and entrepreneurs, more than 280 portfolio companies and 170 million euros in assets under management, Sambrinvest is a major venture capital player in Wallonia. More than an investment fund, Sambrinvest is also a catalyst for the development of local ecosystems, such as biotech, digital and engineering.
amyl therapeutics
LegiaPark
Boulevard Patience et Beaujonc 3, box 12
4000 Liège, Belgium
© Amyl Therapeutics